Just as FDA reviews drugs for humans for safety and effectiveness before they can go on the market, the agency does the same for treatments for animals. Learn how FDA brings new oncology treatments to market and questions to ask your vet about your dog’s cancer diagnosis.
Similar Posts
MEGA 7G 700000 contains hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use MEGA 7G 700000, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.Apotex Inc. – 714137 – 10/31/2025
CGMP/Finished Pharmaceuticals/AdulteratedFDA Drug Competition Action Plan
FDA’s Drug Competition Action Plan (DCAP) encourages robust and timely market competition for generic drugs and helps bring greater efficiency and transparency to the generic drug review process, without sacrificing the scientific rigor underlying our generic drug program.Why Protecting Confidential Information is Key to the FDA’s “Gold Standard”
The FDA must maintain a delicate balance: being a model of openness regarding the scientific basis of its decisions, while safeguarding the proprietary secrets of the industries it regulates as well as personal data.Learning and Education to ADvance and Empower Rare Disease Drug Developers (LEADER 3D)
As part of the Accelerating Rare disease Cures (ARC) Program, CDER’s Rare Diseases Team inaugurated the Learning and Education to Advance and Empower Rare Disease Drug Developers (LEADER 3D) initiative. Learn more.Products Containing 7-OH Can Cause Serious Harm
The FDA recommends that consumers avoid 7-OH products, including foods, dietary supplements and those claiming to treat an ailment or disorder. 7-OH is not approved as a drug by the FDA.